Program Overview

Master’s Degree in Biopharmaceutical Business

Programme Overview

The Master’s Degree in Biopharmaceutical Business is designed for students who wish to develop their professional potential in companies within the pharmaceutical, biotechnology, or medical technology sectors based on the demand these companies have for highly qualified professionals. Both IQS professors and more than 30 professionals from inside the industry will teach lessons and share real case studies related to global companies in this sector.

Objectives

The main objective of the master’s degree is to prepare new professionals who are ready to take on a wide variety of positions within the biopharmaceutical sector in an international work setting who are equipped with a cross-disciplinary technical and business vision of the different areas that make up this relevant industry.

Key Information

• Duration: 1 year
• Credits: 60 ECTS Credits
• Start: October 2025
• Timetable: 6:00 pm to 9:00 pm Three days a week
• Languages: English
• Requirements: Bachelor’s degree in health sciences or individuals who wish to advance their career in the biotechnology or pharmaceutical industries.

Curriculum

Module 1: The Global Biopharmaceutical Business

• The Biomedicine Business & Professional Careers (6 credits)
• R&D, Manufacturing and IP in Biopharma (6 credits)
• Regulatory Affairs & Market Access (3 credits)
• Medical Technologies (3 credits)

Module 2: Technical Areas. Development of New Treatments.

• R&D, Manufacturing and IP in Biopharma (6 credits)
• Regulatory Affairs & Market Access (3 credits)
• Medical Technologies (3 credits)

Module 3: Commercial and Managerial Aspects in the Biopharma Industry

• Marketing, Sales & Communication (3 credits)
• Financials & Entrepreneurship (3 credits)
• Business Development & Strategy (3 credits)
• Leadership & Personal Branding (3 credits)

Admissions Process

• Online pre-registration
• Admission confirmation
• Pre-enrolment
• Enrolment

Prerequisites for Admission

• Hold a university undergraduate degree (or equivalent issued by a higher education institution within the European Higher Education Area) in the area of Health Sciences: Biotechnology, Pharmacy, Chemistry, Biochemistry, Biology, Medicine, or similar.
• A university degree in other fields may be accepted as long as the student demonstrates great interest in building their career in the biopharmaceutical sector (each case will be assessed individually).

Scholarships and Financial Aid

• Academic Excellence
• Financial need
• International Students

Career Opportunities

• Clinical Development
• MSL (Medical Scientific Liaison)
• Sales Manager
• Business Development
• Intellectual Property
• Regulatory Affairs
• Market Access

In-company Internship

• The Master’s Degree in Biopharmaceutical Business features compulsory in-company internships (20 ECTS) within the biopharmaceutical sector for all students.
• IQS has agreements in place with various pharmaceutical, biotechnology, medical technology, and related services companies, all of which boast recognized prestige in the sector and offer students different positions in various departments depending on their needs.
• The in-company internships last for a minimum duration of six months.

Faculty

• Horacio Moreno Manzano, PhD
• Jordi Díaz Ferrero, PhD
• Francesc Prior Sanz, PhD
• Jan-Hinrich Meyer, PhD
• Jordi Martorell López, PhD
• Xavier Berzosa Rodríguez, PhD

Visiting Lecturers

• Agustín Alconada, PhD
• Álex Pérez
• Alfons Carnicero
• Dominique Monferrrer
• Esther García Gil
• Francesc Cartanyá
• Joachim Renken, PhD
• Jordi Aparici
• Jordi Martí
• Judith García
• Julio Castro, PhD
• Lidia Cánovas
• Luis Ruiz, PhD
• Marc Soriano, PhD
• Marc Martinell, PhD
• Marisa Vinyals, PhD
• Marta Palicio, PhD
• Matthias Krings, PhD
• Miquel Romero
• Nerea Blanqué
• Oriol Solà-Morales, PhD
• Pablo Martín-Sáiz
• Pepi Hurtado, PhD
• Pío Orviz, PhD
• Raúl Martín-Ruiz, PhD
• Teresa Tarragó, PhD
• Thomas Eichholtz, PhD
• Wendeline de Zan
• Xavier Luria, MD